Subsequent Events (Details Narrative) - USD ($) |
1 Months Ended | 6 Months Ended |
|---|---|---|
Aug. 31, 2020 |
Jun. 30, 2020 |
|
| Debt instrument maturity date description | Convertible bridge notes plus accrued and capitalized interest of $1,323,636, began to mature through October 2020, with an additional $35,251 in principal and accrued interest maturing in 2021. | |
| Convertible Promissory Note [Member] | QSAM Therapeutics Inc [Member] | Two Tranches [Member] | ||
| Convertible debt | $ 60,000 | |
| Subsequent Event [Member] | Convertible Promissory Note [Member] | QSAM Therapeutics Inc [Member] | ||
| Convertible debt | $ 110,000 | |
| Debt instrument maturity date description | Matures 12 months after the date of the four funding tranches provided by the investor – between June and August 2021. | |
| Debt instrument, interest rate | 8.00% |
| X | ||||||||||
- Definition Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|